DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Mok TSK, Wu YL, Kudaba I, Kowalski DM, Cho BC, Turna HZ. et al.
Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): A randomised, open-label, controlled, phase 3 trial.
Lancet 2019;
393: 1819-30
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.